We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Moves to Disqualify Ketek Trial Investigator
FDA Moves to Disqualify Ketek Trial Investigator
April 14, 2010
Another investigator involved in a study of Sanofi-Aventis’ antibiotic Ketek is facing disciplinary action.